For all the societal changes ushered in by GLP-1 drugs, their lofty price tags limit who can afford them. Many patients stop taking the medications after experiencing undesirable side effects. Others who could benefit have stayed on the sidelines because they don’t want to jab themselves.
A new wave of the medicine is coming that could be even more transformative for human health: pills, more potent injectables and new compounds that might have fewer side effects or could be taken just once a month.
“With this newer generation of medications, we’re not just focusing on weight loss,” said David Lau, an endocrinologist and professor emeritus at the University of Calgary Cumming School of Medicine. “We’re talking about changes beyond what you see on the scale.”
A combination of market competition and government policy is also starting to bring down prices, which means that any new drug will have to be superior to justify a premium price over today’s GLP-1 drugs.
…
Related on the SLP
Semaglutide, [physician-researcher Sean] Wharton said, is “a really beautiful molecule” that could have long-term benefits for conditions like coronary artery disease and osteoarthritis.


















